TY - JOUR
T1 - Neuroimaging and resilience factors -staging of the at-risk mental state?
AU - Smieskova, Renata
AU - Fusar-Poli, Paolo
AU - Riecher-Rössler, Anita
AU - Borgwardt, Stefan
PY - 2012/1
Y1 - 2012/1
N2 - Over the past decade, vulnerability-and psychosis-associated structural and functional brain abnormalities in a population at high clinical risk to develop psychosis were intensively studied. We reviewed the results from studies comparing at-risk mental state (ARMS) individuals with and without subsequent transition to psychosis. Additionally, we introduced a new concept of splitting ARMS population according to the duration of the psychosis risk syndrome and their probability to develop psychosis. Studying the ARMS individuals still vulnerable to psychosis but with lower risk to transit can disclose the possible protective - resilience factors or characteristics. Resilience, understood as ability to recover from change, can be thus applied in the early intervention for high clinical risk for psychosis individuals.
AB - Over the past decade, vulnerability-and psychosis-associated structural and functional brain abnormalities in a population at high clinical risk to develop psychosis were intensively studied. We reviewed the results from studies comparing at-risk mental state (ARMS) individuals with and without subsequent transition to psychosis. Additionally, we introduced a new concept of splitting ARMS population according to the duration of the psychosis risk syndrome and their probability to develop psychosis. Studying the ARMS individuals still vulnerable to psychosis but with lower risk to transit can disclose the possible protective - resilience factors or characteristics. Resilience, understood as ability to recover from change, can be thus applied in the early intervention for high clinical risk for psychosis individuals.
UR - http://www.scopus.com/inward/record.url?scp=84856549214&partnerID=8YFLogxK
U2 - 10.2174/138161212799316046
DO - 10.2174/138161212799316046
M3 - Scientific review articles
C2 - 22239572
AN - SCOPUS:84856549214
SN - 1381-6128
VL - 18
SP - 416
EP - 421
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 4
ER -